BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30612698)

  • 1. [Some important breakthroughs in oncology and hematology in 2018: A selection by the editorial board of Bulletin du Cancer].
    Bay JO; André T; Caux C; Evrard S; Gonçalves A; L'Allemain G; Magné N; Orbach D; Penel N; Rodrigues M; Thariat J; Thiery-Vuillemin A; Wislez M;
    Bull Cancer; 2019 Jan; 106(1):12-23. PubMed ID: 30612698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Which recent results in Oncology and Hematology will have an impact on our practices? The point of vue of Bulletin du Cancer editorial board].
    Vignot S; André T; Gonçalves A; Guièze R; Magné N; Orbach D; Penel N; Thariat J; Wislez M; Bay JO
    Bull Cancer; 2017 Jan; 104(1):6-19. PubMed ID: 28007296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hot topics in 2017 in oncology and hematology. A selection by the editorial board of Bulletin du Cancer].
    Vignot S; André T; Caux C; Bouleuc C; Evrard S; Gonçalves A; Lacroix M; Magné N; Massard C; Mazeron JJ; Orbach D; Rodrigues M; Thariat J; Wislez M; L'Allemain G; Bay JO
    Bull Cancer; 2018 Jan; 105(1):6-14. PubMed ID: 29269176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Major advances in oncology in 2014: the editorial board of the Bulletin du Cancer point of view].
    Massard C; Bay JO; André T; Blay JY; Goncalves A; Orbach D; Wislez M; Thariat J; Magné N; Vignot S
    Bull Cancer; 2015 Jan; 102(1):92-104. PubMed ID: 25609486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What should we remember from 2020?].
    Bay JO; Andre T; Bouleuc C; Gandemer V; Magne N; Orbach D; Pellier I; Penel N; Rodrigues M; Thariat J; Thiery-Villemin A; Wisley M; L'Allemain G; Robert J;
    Bull Cancer; 2021 Jan; 108(1):55-66. PubMed ID: 33419531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A 2021 inventory in oncology news].
    Bay JO; Bouleuc C; Firmin N; Gandemer V; Magne N; Orbach D; Penel N; Rodrigues M; Thiery-Vuillemin A; Wislez M; L'Allemain G; Sabatier R; Robert J;
    Bull Cancer; 2022 Jan; 109(1):8-19. PubMed ID: 34980367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
    Golan T; Milella M; Ackerstein A; Berger R
    J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2015 through the eyes of the Bulletin of Cancer editorial board].
    Magné N; Massard C; Bay JO; André T; Blay JY; Goncalves A; Orbach D; Wislez M; Thariat J; Penel N; Rancoule C; Vignot S
    Bull Cancer; 2016 Jan; 103(1):3-17. PubMed ID: 26782079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Major advances in Oncology in 2013: the editorial board of the Bulletin du Cancer point of view].
    Vignot S; Bay JO; André T; Blay JY; Goncalves A; Massard C; Orbach D; Wislez M; Thariat J; Magné N
    Bull Cancer; 2014 Jan; 101(1):75-92. PubMed ID: 24491669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New frontiers of therapy in hemato-oncology.
    Prabhash K; Bapsy PP
    J Assoc Physicians India; 2003 Nov; 51():1123-4; author reply 1124. PubMed ID: 15260408
    [No Abstract]   [Full Text] [Related]  

  • 11. [American Society of Clinical Oncology (ASCO) 2011 essential data: the editorial board of the Bulletin du Cancer point of view].
    Vignot S; Bay JO; Blay JY; Gonçalves A; Massard C; Thariat J; Wislez M; André T
    Bull Cancer; 2011 Dec; 98(12):1509-23. PubMed ID: 22182714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Following communications made at American Society of Clinical Oncology 2010, what will change our practice? The point of view of the editorial board of Bulletin du Cancer].
    André T; Wislez M; Goncalves A; de La Motte Rouge T; Blay JY; Massard C; Bay JO;
    Bull Cancer; 2010 Dec; 97(12):1551-62. PubMed ID: 21220230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Future-oriented hemato-oncology in times of confusion in health politics].
    Niederwieser D; Hiddemann W
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2385. PubMed ID: 17054052
    [No Abstract]   [Full Text] [Related]  

  • 14. [American Society of Clinical Oncology (ASCO) 2012 essential data: the editorial board of the Bulletin du Cancer point of view].
    Magné N; Bay JO; Blay JY; Gonçalves A; Massard C; Thariat J; Wislez M; André T; Vignot S
    Bull Cancer; 2012 Dec; 99(12):1209-17. PubMed ID: 23306389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Building a National Framework for Adolescent and Young Adult Hematology and Oncology and Transition from Pediatric to Adult Care: Report of the Inaugural Meeting of the "AjET" Working Group of the German Society for Pediatric Oncology and Hematology.
    Escherich G; Bielack S; Maier S; Braungart R; Brümmendorf TH; Freund M; Grosse R; Hoferer A; Kampschulte R; Koch B; Lauten M; Milani V; Ross H; Schilling F; Wöhrle D; Cario H; Dirksen U
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):194-199. PubMed ID: 27983882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highlights of the third International Conference on Immunotherapy in Pediatric Oncology.
    Brehm C; Huenecke S; Pfirrmann V; Rossig C; Mackall CL; Bollard CM; Gottschalk S; Schlegel PG; Klingebiel T; Bader P
    Pediatr Hematol Oncol; 2013 Aug; 30(5):349-66. PubMed ID: 23758210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical development of immuno-oncology in China.
    Wu DW; Huang HY; Tang Y; Zhao Y; Yang ZM; Wang J; Wang SH; Yu Y; Fang Y; Fang H; Bai Y; Sun C; Fan Q; Yu AQ; Wang HL; Du CX; Chen K; Huang MD; Zhang Y; Li N; Xu BH; Sun Y; He J
    Lancet Oncol; 2020 Aug; 21(8):1013-1016. PubMed ID: 32758460
    [No Abstract]   [Full Text] [Related]  

  • 18. Landscape of early clinical trials for childhood and adolescence cancer in Spain.
    Bautista F; Gallego S; Cañete A; Mora J; Diaz de Heredia C; Cruz O; Fernández JM; Rives S; Madero L; Castel V; Cela ME; Ramírez G; Sábado C; Acha T; Astigarraga I; Sastre A; Muñoz A; Guibelalde M; Moreno L
    Clin Transl Oncol; 2016 Jul; 18(7):708-13. PubMed ID: 26489424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematological malignancies: a primer.
    Haddad RY
    Dis Mon; 2012 Apr; 58(4):151-2. PubMed ID: 22449364
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunotherapy in lung cancer: New concepts].
    Goubet AG; Livartowski A; Romano E
    Rev Mal Respir; 2018 Jun; 35(6):642-651. PubMed ID: 29941206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.